Cargando…
Validation of prognostic signature and exploring the immune-related mechanisms for NR3C2 in clear cell renal cell carcinoma
BACKGROUND: Previous studies have verified that NR3C2 inhibits tumor cell proliferation, invasion, and migration. However, there is a lack of independent validation cohorts for verifying the prognostic value of NR3C2 in clear cell renal cell carcinoma (ccRCC), and its underlying antitumor mechanisms...
Autores principales: | Chen, Daoxun, Yin, Zhenjie, Chen, Yongmei, Bai, Yuanyuan, You, Bingyong, Sun, Yingming, Wu, Yongyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643972/ https://www.ncbi.nlm.nih.gov/pubmed/37969386 http://dx.doi.org/10.21037/tcr-23-846 |
Ejemplares similares
-
CDCA3 Predicts Poor Prognosis and Affects CD8(+) T Cell Infiltration in Renal Cell Carcinoma
por: Bai, Yuanyuan, et al.
Publicado: (2022) -
A 20-Gene Signature Predicting Survival in Patients with Clear Cell Renal Cell Carcinoma Based on Basement Membrane
por: Yin, Zhenjie, et al.
Publicado: (2023) -
Development and Validation of a Prognostic Gene Signature in Clear Cell Renal Cell Carcinoma
por: Zhan, Chuanchuan, et al.
Publicado: (2021) -
Establishment and validation of a novel anoikis-related prognostic signature of clear cell renal cell carcinoma
por: Liu, Yankuo, et al.
Publicado: (2023) -
Identification of an Autophagy-Related Prognostic Signature for Clear Cell Renal Cell Carcinoma
por: Chen, Mei, et al.
Publicado: (2020)